Clinical and electroencephalographic characteristics of Jeavons syndrome.
- Author:
Zhi-xian YANG
1
;
Xiao-yan LIU
;
Jiong QIN
;
Yue-hua ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Age of Onset; Anticonvulsants; administration & dosage; therapeutic use; Child; Child, Preschool; Electroencephalography; Electromyography; Epilepsies, Myoclonic; diagnosis; drug therapy; physiopathology; Epilepsy, Tonic-Clonic; diagnosis; drug therapy; physiopathology; Eyelids; Female; Follow-Up Studies; Humans; Male; Myoclonus; diagnosis; drug therapy; physiopathology; Photic Stimulation; methods; Retrospective Studies; Seizures; physiopathology; Syndrome; Valproic Acid; administration & dosage; therapeutic use
- From: Chinese Journal of Pediatrics 2012;50(6):445-449
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVEThe study was designed to examine the clinical and electroencephalographic characteristics of children with Jeavons syndrome.
METHODVideo-electroencephalography (VEEG) monitoring was carried out in 9 patients with Jeavons syndrome. The clinical and electroencephalographic characteristics, treatment and prognoses were analyzed.
RESULTOf the 9 patients, 8 were female, and 1 was male. The onset age of children with eyelid myoclonia (EM) was from 3 to 9 years old. It was obtained through the chief complaint, prosecution or VEEG monitoring. Three cases were misdiagnosed and 2 cases were overlooked initially. Seven out of 9 patients had generalized tonic clonic seizures (GTCS) during the course of disease, of whom 5 experienced only one episode. GTCS was the cause for the first visits to hospital in 5 patients. Since the clinical manifestations of EM with or without absence were often slight, VEEG monitoring with eye closure and intermittent photic stimulation tests helped to induce discharges and seizures. Eye closure was more potent than intermittent photic stimulation as a triggering factor. Ictal EEG showed 3 - 6 Hz generalized spike and waves and polyspikes burst. The main treatment option was valproate monotherapy (6 cases) or combined with other antiepileptic drugs (1 case). Levetiracetam, lamotrigine and topiramate were also used in patients and effective to some degree. Two patients lost follow up. The age of 7 patients at follow-up ranged from 9 y to 15 y. Seizures were controlled in 1 case, suspiciously controlled in 1 case, decreased in frequency in 4 cases and were still frequent in 1 case. During follow-up, normal intelligence was found in the former 2 cases, difficult learning in 2 cases, and slightly intellectual impairment in 2 cases.
CONCLUSIONJeavons syndrome is one of the idiopathic generalized epilepsies characterized by EM with or without absence. The age of seizure onset might be difficult to be exactly established, as EM was often misinterpreted and overlooked initially. Clinical history combined with VEEG monitoring with eye closure and intermittent photic stimulation tests could diagnose this disease. Valproate and other new antiepileptic drugs were effective for this disease. Jeavons syndrome is a lifelong disorder. Seizures sometimes could be well controlled. When seizures were resistant to treatment, cognitive and intellectual impairment might occur.